Stockscreener 앱 받기
0.5101
3.77%
-0.0199
전일 마감가:
$0.53
열려 있는:
$0.52
하루 거래량:
26,073
Relative Volume:
0.12
시가총액:
$786.27K
수익:
$743.00K
순이익/손실:
$-7.63M
주가수익비율:
-0.17
EPS:
-3
순현금흐름:
-
1주 성능:
-17.53%
1개월 성능:
-22.68%
6개월 성능:
-67.52%
1년 성능:
-79.27%
1일 변동 폭
$0.51
$0.52
1주일 범위
$0.51
$0.6262
52주 변동 폭
$0.51
$3.12
캔 파이트 바이오파마 Stock (CANF) Company Profile
명칭
Can-Fite Biopharma Ltd ADR
전화
972 3 924 1114
주소
10 Bareket Street, Kiryat Matalon PO Box 7537, Petah-Tikva
CANF을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CANF
Can-Fite Biopharma Ltd ADR
|
0.5101 | 9.05M | 743.00K | -7.63M | 0 | -3.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
406.67 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.15 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
551.31 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
801.29 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
328.50 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
캔 파이트 바이오파마 Stock (CANF) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2017-08-11 | 개시 | Maxim Group | Buy |
| 2016-10-19 | 재개 | ROTH Capital | Buy |
| 2016-08-29 | 재개 | Rodman & Renshaw | Buy |
| 2015-11-30 | 재확인 | H.C. Wainwright | Buy |
| 2015-03-31 | 재확인 | H.C. Wainwright | Buy |
| 2015-03-30 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2014-12-29 | 재확인 | ROTH Capital | Buy |
| 2014-11-18 | 개시 | H.C. Wainwright | Buy |
모두보기
캔 파이트 바이오파마 주식(CANF)의 최신 뉴스
Why Can Fite Biopharma Ltd Sponsored ADR stock could outperform next yearGlobal Markets & Weekly Return Optimization Alerts - newser.com
Will Can Fite Biopharma Ltd Sponsored ADR stock beat growth indexesMarket Movement Recap & Free Weekly Watchlist of Top Performers - newser.com
Why pension funds invest in Can Fite Biopharma Ltd Sponsored ADR stockJuly 2025 Selloffs & Reliable Trade Execution Plans - newser.com
Why Can Fite Biopharma Ltd Sponsored ADR stock fits value portfolios2025 Bull vs Bear & Smart Allocation Stock Reports - newser.com
Is Can Fite Biopharma Ltd Sponsored ADR stock expanding market penetration2025 Historical Comparison & AI Powered Buy and Sell Recommendations - newser.com
Is Can Fite Biopharma Ltd Sponsored ADR stock a contrarian opportunityEarnings Miss & Real-Time Volume Triggers - newser.com
Why Can Fite Biopharma Ltd Sponsored ADR stock is a strong buy callEarnings Beat & High Accuracy Swing Entry Alerts - newser.com
Analyzing recovery setups for Can Fite BioPharma Ltd. Depositary Receipt investorsJuly 2025 Sector Moves & AI Driven Stock Movement Reports - newser.com
Institutional scanner results for Can Fite BioPharma Ltd. Depositary ReceiptMarket Performance Recap & Smart Money Movement Alerts - newser.com
Developing predictive dashboards with CISS dataTreasury Yields & Technical Analysis for Trade Confirmation - newser.com
Is a relief rally coming for Inovio Pharmaceuticals Inc. holders2025 Technical Overview & Risk Controlled Swing Trade Alerts - newser.com
Smart tools for monitoring Can Fite BioPharma Ltd. Depositary Receipt’s price action2025 Market Overview & Precise Buy Zone Tips - newser.com
Order flow analysis tools used on BOOMWatch List & Accurate Technical Buy Alerts - newser.com
Can-Fite BioPharma (NYSE:CANF) Given Buy Rating at D. Boral Capital - Defense World
Can swing trading help recover from Crane NXT Co. lossesMarket Growth Summary & AI Optimized Trade Strategies - Newser
Has FVRR formed a bullish divergence2025 Key Lessons & Low Risk High Win Rate Picks - Newser
Applying sector rotation models to Vale S.A. Depositary ReceiptJuly 2025 Catalysts & Reliable Price Action Trade Plans - Newser
Sentiment analysis tools applied to Vertical Aerospace Ltd.2025 Dividend Review & Weekly Setup with ROI Potential - Newser
Using RSI to spot recovery in ALDFUJuly 2025 Market Mood & Precise Swing Trade Entry Alerts - Newser
Fragrances Inc.Earnings Growth Report & Stepwise Swing Trade Plans - Newser
캔 파이트 바이오파마 (CANF) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.11%
2.69%
자본화:
|
볼륨(24시간):